Revolution Medicines, Inc. RVMD Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -76.7%-18.6pp | -58.1%+2.7pp | -60.8%-14.1pp | -46.6%-9.9pp | -36.7%-7.3pp | |
| Return on assets | -59.4%-13.3pp | -46.1%+1.8pp | -47.9%-9.5pp | -38.3%-5.7pp | -32.6%-6.7pp | |
| Return on invested capital | -89.6%-17.2pp | -72.4%-3.1pp | -69.4%-10.1pp | -59.3%-12.9pp | -46.4%-1.5pp | |
| Liquidity | ||||||
| Current ratio | 6.8×-0.3× | 7.1×-0.9× | 8.1×-3.7× | 11.8×-1.7× | 13.5×-0.7× | |
| Quick ratio | 6.8×-0.3× | 7.1×-0.9× | 8.1×-3.7× | 11.8×-1.7× | 13.5×-0.7× | |
| Cash ratio | 1.5×+0.2× | 1.3×+0.4× | 0.9×-1.3× | 2.2×+0.1× | 2.1×-1.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Interest coverage | -38.1×+10.7× | -48.8×+35.6× | -84.3×+951× | -1,035.2×— | —— | |
| Per Share | ||||||
| Book value per share | $7.57-11.8% | $8.58+1.7% | $8.44-14.7% | $9.89-10.4% | $11.05-18.2% | |
| Valuation | ||||||
| Market capitalization | $19.27B+25.2% | $15.4B+76.4% | $8.73B+17.1% | $7.46B+13.4% | $6.57B-18.7% | |
| Enterprise value | $18.99B+25.1% | $15.17B+75.0% | $8.67B+20.7% | $7.19B+12.7% | $6.37B-17.0% | |
| Price / book | 12.8×+3.4× | 9.4×+4.0× | 5.5×+1.5× | 4×+0.8× | 3.2×-0.4× | |
| Free cash flow yield | -5.6%+0.4pp | -5.9%+3.0pp | -8.9%+0.5pp | -9.4%-0.2pp | -9.2%-2.1pp | |
| Earnings yield | -7.1%+0.2pp | -7.3%+3.7pp | -11%-0.1pp | -10.9%-0.3pp | -10.6%-3.2pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Revolution Medicines, Inc.'s ratios come from?
- Every ratio is computed from Revolution Medicines, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.